Telomir Pharmaceuticals (TELO) Earnings Date & Reports

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TELO is expected to report earnings to fall 28.57% to -5 cents per share on September 03

Telomir Pharmaceuticals TELO Stock Earnings Reports

Q2'25

Est.

$-0.05

Q1'25

Missed

by $0.01

The last earnings report on May 28 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 148.75K shares outstanding, the current market capitalization sits at 55.36M.

View a ticker or compare two or three

Compare

TELO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TELO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

855 N Wolfe Street

Phone

+1 737 289-0835

Employees

Web

https://www.telomirpharma.com